← Open Payments lookup

REBECCA SCARBROUGH: Open Payments

NPI 1518443134 · LAUREL, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$673 in 31 payments from 11 companies in 2025. Trend: 2023 $618 · 2024 $372 · 2025 $673

Food & beverage: $673
CompanyPaymentsAmount
Novo Nordisk Inc7$177
Abbott Laboratories9$169
AstraZeneca Pharmaceuticals LP2$85
Tandem Diabetes Care, Inc.2$53
Bayer Healthcare Pharmaceuticals Inc.3$53
Lilly USA, LLC2$34
GlaxoSmithKline, LLC.2$30
Janssen Pharmaceuticals, Inc1$22
Xeris Pharmaceuticals, Inc.1$19
Sequel Med Tech, LLC1$16

Products named: FREESTYLE LIBRE, AIRSUPRA, Wegovy, Ozempic, t:slim X2 Insulin Pump with Control-IQ, Kerendia, JARDIANCE, TRELEGY ELLIPTA.

Industry payments across MS — which companies pay providers there.